Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
Clinical trial NCT02468375 · COMPLETED
Trial details
- NCT number
- NCT02468375
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-10-01
- Enrollment
- 434
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.